Allurion Technologies (ALUR) Cash from Investing Activities (2022 - 2024)
Allurion Technologies (ALUR) posted Cash from Investing Activities of -$72000.0 for Q3 2024, up 83.45% on a QoQ basis from -$435000.0 in Q2 2024, and up 91.0% year-over-year from -$37696.3 in Q4 2023.
Allurion Technologies (ALUR) Cash from Investing Activities (2022 - 2024) Analysis & Trends
Allurion Technologies' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$72000.0 for Q3 2024.
- Quarterly Cash from Investing Activities rose 91.0% year-over-year to -$72000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2024 was -$611000.0 (up 61.96% YoY) and the FY2024 annual result came in at -$611000.0, up 61.96% from the prior year.
- Cash from Investing Activities was -$72000.0 for Q3 2024 at Allurion Technologies, up from -$435000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $157000.0 in Q3 2022 and bottomed at -$800000.0 in Q3 2023.
- A 3-year average of -$279888.9 and a median of -$277000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities tumbled 609.55% — and 2024, when it surged 91.0%.
- Allurion Technologies' Cash from Investing Activities stood at -$459000.0 in 2022, then gained by 13.29% to -$398000.0 in 2023, then soared by 81.91% to -$72000.0 in 2024.
- Business Quant data shows ALUR's Cash from Investing Activities at -$72000.0 in Q3 2024, -$435000.0 in Q2 2024, and -$104000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -72,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -435,000.00 |
| Jun 30, 2024 | -435,000.00 |
| Mar 31, 2024 | -104,000.00 |
| Mar 31, 2024 | -104,000.00 |
| Dec 31, 2023 | -398,000.00 |
| Dec 31, 2023 | -398,000.00 |
| Sep 30, 2023 | -800,000.00 |
| Sep 30, 2023 | -800,000.00 |
| Jun 30, 2023 | -131,000.00 |
| Jun 30, 2023 | -131,000.00 |
| Mar 31, 2023 | -277,000.00 |
| Mar 31, 2023 | -277,000.00 |
| Dec 31, 2022 | -459,000.00 |
| Dec 31, 2022 | -459,000.00 |
| Sep 30, 2022 | 157,000.00 |
| Sep 30, 2022 | 157,000.00 |